Among these efforts, inhibition of acetylcholinesterase (AChE), which increases the accumulation of ACh in the synaptic cleft, was proved to be efficacious in improving cognitive function, and is currently the main therapeutic strategy for AD patients [6]. The gene discussed is ACHE; the disease is Alzheimer disease.